OBJECTIVE: To determine the impact of therapy on the reported health-related quality of life (HRQoL) in children with primary immune thrombocytopenia (ITP) using the Kids ITP tool (KIT). DESIGN: Secondary data analysis of the international and North American KIT validation studies. RESULTS: 217 children from 6 countries participated in the two studies. The majority of treatments occurred in children with newly diagnosed ITP. There was no statistical difference in age, platelet count and bleeding severity at presentation in those who physicians chose to treat or observe. Self-reported KIT scores did not differ between the two groups. The KIT parent-proxy scores were significantly worse for newly diagnosed children receiving treatment, especially following prednisone. CONCLUSIONS: Treatment of ITP does not improve, and may worsen, the HRQoL of children with ITP as measured using the KIT.
OBJECTIVE: To determine the impact of therapy on the reported health-related quality of life (HRQoL) in children with primary immune thrombocytopenia (ITP) using the Kids ITP tool (KIT). DESIGN: Secondary data analysis of the international and North American KIT validation studies. RESULTS: 217 children from 6 countries participated in the two studies. The majority of treatments occurred in children with newly diagnosed ITP. There was no statistical difference in age, platelet count and bleeding severity at presentation in those who physicians chose to treat or observe. Self-reported KIT scores did not differ between the two groups. The KIT parent-proxy scores were significantly worse for newly diagnosed children receiving treatment, especially following prednisone. CONCLUSIONS: Treatment of ITP does not improve, and may worsen, the HRQoL of children with ITP as measured using the KIT.
Entities:
Keywords:
General Paediatrics; Haematology; ITP; quality of life
Authors: Katja M J Heitink-Pollé; Lotte Haverman; Kim V Annink; Sarah J Schep; Masja de Haas; Marrie C A Bruin Journal: Haematologica Date: 2014-06-20 Impact factor: 9.941
Authors: Drew Provan; Donald M Arnold; James B Bussel; Beng H Chong; Nichola Cooper; Terry Gernsheimer; Waleed Ghanima; Bertrand Godeau; Tomás José González-López; John Grainger; Ming Hou; Caroline Kruse; Vickie McDonald; Marc Michel; Adrian C Newland; Sue Pavord; Francesco Rodeghiero; Marie Scully; Yoshiaki Tomiyama; Raymond S Wong; Francesco Zaja; David J Kuter Journal: Blood Adv Date: 2019-11-26
Authors: Heng Zhang; Li Wang; Meijie Quan; Jie Huang; Peng Wu; Qin Lu; Yongjun Fang Journal: Health Qual Life Outcomes Date: 2016-03-15 Impact factor: 3.186